UK markets open in 5 hours 25 minutes

Mereo BioPharma Group plc (MREO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9900-0.0500 (-1.64%)
At close: 04:00PM EDT
2.9800 -0.01 (-0.33%)
After hours: 05:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.0400
Open3.0300
Bid2.9700 x 400
Ask3.0000 x 600
Day's range2.8750 - 3.0300
52-week range0.9200 - 4.3600
Volume507,524
Avg. volume1,040,069
Market cap426.428M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.1500
Earnings date29 Mar 2024 - 02 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.26
  • GlobeNewswire

    Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

    LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the first quarter ended March 31, 2024, and provided an update on recent corporate highlights. The Company reported cash and cash equivalents of $48.7 million as of March 31, 2024 and continues to expect this to fund its operations into 2026. “2024 is off to an exciting start fo

  • Zacks

    MEREO BIOPHARMA (MREO) Loses -12.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

    The heavy selling pressure might have exhausted for MEREO BIOPHARMA (MREO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

  • GlobeNewswire

    Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

    LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer, will participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 10:15am ET / 03:15pm BST. A live audio webcast of the presentation can be accessed through the Investors section of the Compa